Literature DB >> 434675

Persistence of neutrophil hypersegmentation during recovery from megaloblastic granulopoiesis.

B J Nath, J Lindenbaum.   

Abstract

We studied the rate of disappearance of neutrophil hypersegmentation in 23 patients with megaloblastic anemia during therapy with vitamin B12 and folic acid. In 14 patients with uncomplicated megaloblastic anemia, the neutrophil lobe average began to fall towards normal 11.4 +/- 0.3 (SEM) days after treatment was begun and became normal by 13.9 +/- 0.6 days. In nine patients with associated inflammatory disorders, the lobe average returned to normal more rapidly. In six initially neutropenic patients, a five-fold increase in total granulocyte count occurred by the eighth day and a seven-fold increment in the total number of circulating hypersegmented neutrophils. Granulocyte folate concentrations in five folate-deficient patients rose to normal levels within 4 to 7 days of starting therapy. Hypersegmentation thus persists for many days after correction of neutropenia and restoration of normal granulocyte folate levels have occurred. We conclude that cobalamin and folate are needed at two different steps in granulopoiesis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 434675     DOI: 10.7326/0003-4819-90-5-757

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  2 in total

1.  CSF 5-Methyltetrahydrofolate Serial Monitoring to Guide Treatment of Congenital Folate Malabsorption Due to Proton-Coupled Folate Transporter (PCFT) Deficiency.

Authors:  A Torres; S A Newton; B Crompton; A Borzutzky; E J Neufeld; L Notarangelo; G T Berry
Journal:  JIMD Rep       Date:  2015-05-26

2.  Juvenile cobalamin deficiency in a 17-year-old child with autonomic dysfunction and skin changes.

Authors:  Abdul Hafeez Siddiqui; Aamir Ansari; Cameron M Beech; Nidhi P Shah; Stephan M Tanner; Sharada A Sarnaik
Journal:  J Pediatr Hematol Oncol       Date:  2012-03       Impact factor: 1.289

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.